Repository logo
 
Publication

Morphine patient controlled analgesia for postoperative analgesia in patients who have transplanted cadaver donor kidneys

dc.contributor.authorMadeira, I.
dc.contributor.authorFrada, R.
dc.contributor.authorMarvão, J.
dc.contributor.authorCruz, F.
dc.contributor.authorCasal, M.
dc.contributor.authorCosta, E.
dc.date.accessioned2011-06-03T14:50:03Z
dc.date.available2011-06-03T14:50:03Z
dc.date.issued2011-02
dc.description.abstractIntroduction. Patients who have chronic renal disease present challenges to anesthesiologists because of the sequelae of the underlying disease. Postoperative pain is usually mild to moderate after renal transplantation and is a concern because of underlying co-morbidities and variable responses of the graft. Effective postoperative pain management contributes to a a successful outcome after renal transplantation. Methods. A retrospective study, based on the collected data from clinical process and registration of the acute pain unit. Results. During 2007 and 2008, 124 patients were transplanted with cadaver donor kidneys. The final sample included 55 patients, namely 67% males and 33% females, whose ages range between 15 and 75 years (average, 47.23 years). Their American Society of Anesthesiologists physical status classification was 4 in 71% and 3 in 29%. Analgesia during surgery used a fentanyl, paracetamol and morphine protocol (n 47) or fentanyl, paracetamol, morphine, and local anesthetic infiltration (n 8). The postoperative pain was quantified using a numerical rating scale (0–4) with mean value of 1.07 on day 1, a mean value of 1 on day 2, and a mean value of 0.67 on day 3. Postoperative analgesia with morphine patient-controlled analgesia was used for every patient, combined with paracetamol in 89% of cases. The average number of bolus demands was 60 with 26.4 effective boluses, the mean total administered dose was 26.6 mg. The major side effects were constipation (18%), pruritus (14%), nausea (13%), and vomiting (1.8%). The following relations were significance: age and score of pain, pruritus and total dose of morphine, preoperative analgesia, and pain score on day 2. Conclusions. Our results suggest that analgesia with morphine patient-controlled analgesia was an effective method to achieve control of postoperative pain in this population with few side effects.por
dc.description.versioninfo:eu-repo/semantics/acceptedVersion
dc.identifier.citationMADEIRA, I. [et. al.] - Morphine Patient Controlled Analgesia for Postoperative Analgesia in Patients Who Have Transplanted Cadaver Donor Kidneys. In 9th Luso Brazilian Congress of Transplant. Porto, Portugal, 2-5 Outubro, 2010 - Transplantation Proceedings, 43, 125–130 (2011)por
dc.identifier.doi10.1016/j.transproceed.2010.12.042
dc.identifier.eid79951784652
dc.identifier.pmid21335169
dc.identifier.urihttp://hdl.handle.net/10400.14/4378
dc.identifier.wos000287679100023
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherElsevierpor
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectRenal transplantationpor
dc.subjectMorphinepor
dc.titleMorphine patient controlled analgesia for postoperative analgesia in patients who have transplanted cadaver donor kidneyspor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage130por
oaire.citation.startPage125por
oaire.citation.titleTransplantation Procedingspor
person.familyNameCosta
person.givenNameElisio
person.identifier606269
person.identifier.ciencia-id6612-4AB7-363B
person.identifier.orcid0000-0003-1158-1480
person.identifier.ridK-1990-2013
person.identifier.scopus-author-id7402527214
rcaap.rightsopenAccesspor
rcaap.typearticlepor
relation.isAuthorOfPublication48424466-ddc6-4188-8745-8e72e4bdd1f9
relation.isAuthorOfPublication.latestForDiscovery48424466-ddc6-4188-8745-8e72e4bdd1f9

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
38122793.pdf
Size:
400.07 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.44 KB
Format:
Item-specific license agreed upon to submission
Description: